Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
6h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
7h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
9h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
16h agoBuffalo Potash Files Annual Information Form and New Technical Report
17h agoIonik Announces 30-Day Extension of Senior Debt Facility
Galderma Group Ag logo

Galderma Group Ag

About

158.65CHF-0.15 -0.09%
Closed • Updated at 20:10 GMT+00:00
Market Cap$47.35B
P/E Ratio74.85
Volume273.6K
Beta0.33
RSI49.80
Gross Margin68.67%
Health TechnologyPharmaceuticals: Major

Galderma Group Ag — investor relations, events, news, and company updates on 6ix.

Latest News

Yesterday
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
Apr 23 2026
Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency
Apr 22 2026
Galderma Shareholders Approve All Annual General Meeting Proposals
Apr 16 2026
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
Apr 9 2026
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause

Community Chat

Ask AI

Try asking
6ix6ixAIEvents